Ballantyne Plastic Surgery Changes Hands in Charlotte Healthcare Deal
Event summary
- Ballantyne Plastic Surgery, a 30-year-old Charlotte aesthetic practice, acquired by Alexis Miller and Gen3 Innovations Lab Aesthetics and Wellness Group on May 21, 2026.
- Deal backed by New Majority Capital, an impact investing firm supporting underrepresented entrepreneurs.
- Founder Dr. Thomas G. Liszka transitions ownership to next-generation operator Alexis Miller, who brings media and tech experience.
- Viking Mergers & Acquisitions facilitated the transaction, emphasizing continuity and legacy preservation.
The big picture
This transaction reflects a broader trend of founder-led healthcare practices transitioning to next-generation operators, particularly in high-growth markets like Charlotte. The deal pairs an experienced operator with mission-aligned capital, avoiding the common pitfall of absorbing smaller practices into larger platforms. The involvement of New Majority Capital highlights the growing role of impact investing in facilitating these orderly transitions.
What we're watching
- Legacy Preservation
- Whether Alexis Miller can maintain Ballantyne Plastic Surgery's patient-centered reputation while expanding its service offerings.
- Growth Strategy
- How Gen3 Innovations Lab will leverage its media and tech background to drive practice growth in Charlotte's competitive healthcare market.
- Impact Investing
- The pace at which New Majority Capital-backed acquisitions will reshape small business ownership in the healthcare sector.
Related topics